3Abhirup J, Mansour K P, Slattery R M. Advances in our un- derstanding of the pathophysiology of Type?l diabetes: lessons from the NOD mouse[J]. Clinical Science, 2014, 126 (1):1-18.
4Eisenbarth G S.Type 1 diabetes:molecular, cellular and clin- ical immunology[J]. Advances in Experimental Medicine & Biology, 2004(552):306-310.
6Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transport- er ZnT8 (Slc30A8) is a major autoantigen in human type 1 dia- betes. Proc Natl Acad Sei USA, 2007, 104:17040-17045.
7Eisenbarth GS,Jeffrey J. The natural history of type 1A diabe- tes. Arq Bras Endocrinol Metab, 2008, 52:146-155.
8Kawabata Y, Ikegami H, Kawaguehi Y, et al. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabe- tes. Diabetes, 2002, 51:545-551.
9Williams AJ, Aitken RJ, Chandler MA, et al. Autoantibodies to islet antigen-2 are associated with HLA-DRB1 07 and DRB1 * 09 haplotypes as well as DRB1 * 04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2. Diabetologia, 2008, 51:1444-1448.
10Qu HQ, Polychronakos C. The effect of the MHC locus on autoantibodies in type 1 diabetes. J Med Genet, 2009, 46:469- 471.
